Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs - Nasdaq

Submitted by Anonymous (not verified) on Fri, 03/08/2019 - 06:45

Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs  NasdaqThis week, J&J JNJ gained FDA approval for its antidepressant, Spravato (esketamine). It was the first approval for a depression drug in decades. Lilly LLY said ...